1. Home
  2. Publications
  3. Figure 1 from Imaging Glioblastoma Response...

Figure 1 from Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism

Abstract:
<p><sup>2</sup>H NMR measurements of labeled fumarate, malate, and water in cell culture medium. <b>A</b> and <b>B,</b> Representative <sup>2</sup>H NMR spectra of medium from untreated S2 cells (<b>A</b>) and from cells 24 hours after the last chemoradiotherapy treatment (5 Gy per fraction, 15 Gy in total, and 50 μmol/L temozolomide; <b>B</b>), 2 hours after the addition of 5 mmol/L [2,3-<sup>2</sup>H<sub>2</sub>]fumarate. Deuterated fumarate, malate, and water concentrations in medium from untreated S2 (<b>C</b>), A11 (<b>F</b>), and U87 (<b>I</b>) cells and treated S2 (<b>D</b>), A11 (<b>G</b>), and U87 (<b>J</b>) cells at the indicated times after addition of 5 mmol/L [2,3–<sup>2</sup>H<sub>2</sub>]fumarate. Rates of labeled malate production in untreated and treated S2 (***, <i>P</i> = 0.0028; <b>E</b>), A11 (*, <i>P</i> = 0.0105; <b>H</b>), and U87 (**, <i>P</i> = 0.0075; <b>K</b>) cell suspensions (mean ± SD; <i>n</i> = 3 biological replicates). Cell viability was measured in control (<b>L</b>) and chemoradiotherapy (<b>M</b>)-treated S2, A11, and U87 cells at the indicated time points following collection of the media samples.</p>
Authors:
F Hesse, AJ Wright, V Somai, F Bulat, F Kreis, KM Brindle
Publication date:
24th Nov 2025
Full text
DOI